Furthermore, elevated plasma levels of soluble CD39 in COVID-19 patients are associated with prolonged hospitalization and serve as independent predictors of admission to the intensive care unit, suggesting that soluble CD39 may act as a potential biomarker for disease severity in COVID-19 [217]. Here, ENTPD1 is linked to COVID-19.